Search Results
Aug 06, 2026, 11:15 ET Delphinus Engineering Appoints Gray Beck as Chief Strategy Officer and Jerry Punderson to its Board of Directors
its technical capabilities, and pursue strategic acquisitions in support of the readiness of the U.S. Navy."Gray and Jerry each bring something rare to Delphinus. Gray has helped build and scale government services companies and knows how to turn strategy into disciplined execution. Jerry understands
More news about: Bluestone Investment Partners
Aug 06, 2026, 10:07 ET SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 28, 2026 in Bloom Energy Corporation Lawsuit - BE
"supply chain does not have significant exposure to China." As averred in the action, the Company in fact allegedly obtained scandium, a rare earth dopant essential to its solid oxide fuel cells, through intermediaries that sourced the metal from China, thereby understating exposure to Beijing's
More news about: SueWallSt.com
Aug 06, 2026, 09:33 ET SQAIRZ Appoints Michael Ferlauto as VP of Sales to Accelerate National Retail and Omnichannel Expansion
across multiple sports, helping establish the company as an emerging force in performance footwear."SQAIRZ possesses something that's increasingly rare in today's footwear industry: genuine product innovation supported by measurable performance benefits and passionate customer advocacy," Ferlauto said.
More news about: SQAIRZ
Aug 06, 2026, 09:19 ET Privacy Bee Becomes the First and Only Data Removal Service to Earn a Perfect 5-Star Rating From PCMag
Protection With Industry-Leading Broker Coverage." Rubenking first evaluated Privacy Bee in 2021 and returned five years later to conclude that it "merits a rare five-star rating," a score PCMag labels Exemplary.PCMag recognizes three Editors' Choice services in the category, and only Privacy Bee holds
More news about: Privacy Bee
Aug 06, 2026, 09:00 ET Oceania Cruises® Launches Curated Conversations
acclaimed actress and director best known for her role in "Raiders of the Lost Ark," aboard Oceania Vista®. The program offers guests rare opportunities to hear firsthand stories, exchange ideas and engage directly with remarkable individuals in an intimate luxury setting."Curated
More news about: Oceania Cruises
Aug 06, 2026, 08:37 ET Belgian Boys Welcomes Louisa Lawless as Chief Commercial Officer to Lead Next Phase of Growth
conversation.""I've admired Belgian Boys from the outside for a long time; the brand has real permission to create a new category, and that's a rare thing in CPG," said Lawless. "I'm energized by the opportunity to bring my experience in scaling emerging brands, building high-performing commercial
More news about: Belgian Boys
Aug 06, 2026, 08:30 ET Roche expands cyclospora testing portfolio to support U.S. public health response
malaria, and infections passed from mother to baby, like rubella. Last month, Roche developed a RUO molecular PCR test within six days to detect the rare Ebola Bundibugyo virus and to support response efforts in Central and East Africa.The two new tests are used with the
More news about: ROCHE DIAGNOSTICS CORPORATION
Aug 06, 2026, 08:24 ET RARE BEAUTY BRANDS AND JCPENNEY REOPEN APPLICATIONS FOR 2026 LIFT BEAUTY ACCELERATOR TO SUPPORT UNDERREPRESENTED FOUNDERS
close on August 21st. About Rare Beauty BrandsRare Beauty Brands' mission is to develop and scale unique brands with a truly positive impact, that inspire and empower. In a word, rare. Rare Beauty Brands (RBB) is the parent company of skincare-meets-selfcare
More news about: Rare Beauty Brands
Aug 06, 2026, 08:23 ET New American Funding Adds Christian Johnson and Shane Masterman, with $2 Billion in Combined Career Volume, to Launch Cantera Home Lending in Dallas-Fort Worth
execution, and collaboration, all in service of helping people secure a home they can call their own," said Christian Johnson. "That kind of culture is rare, and it told us everything we needed to know when choosing them as the partner for our team and our clients."To connect with Christian Johnson
More news about: New American Funding
Aug 06, 2026, 08:15 ET Ascend Analytics Appoints Keith Davies as Chief Technology Officer
achieve a new level of excellence in our ability to deliver high-quality, high-value solutions to our customers.""Ascend has built something rare: independent analytics that customers trust with their most complex power market decisions, and forecasts that stand at the foundation of more than $50
More news about: Ascend Analytics
Aug 06, 2026, 08:00 ET Providence™ Medical Technology Appoints Lane Major as President & Chief Executive Officer
Providence is exactly that kind of company. Its differentiated platform is strengthened by rigorous clinical evidence, including the Level 1 data that is rare in our space. That combination is what makes Providence so special and the category leader in TSF. I am honored to partner with the Board, this team,
More news about: Providence Medical Technology, Inc.
Aug 06, 2026, 07:30 ET Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS
CARE Program of the Center for Drug Evaluation (CDE), National Medical Products Administration (NMPA), which facilitates the accelerated development of rare disease therapies.About ALSAmyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease affecting nerve cells
More news about: Ractigen Therapeutics
Aug 06, 2026, 07:05 ET REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights
its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic
More news about: REGENXBIO Inc.
Aug 06, 2026, 07:00 ET Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors
Chief Executive Officer and Chairman of Biohaven. "His firsthand experience building and investing in category-defining AI companies gives our Board a rare, forward-looking vantage point as we integrate new computational approaches into how we discover and develop medicines for patients with serious diseases.""Biohaven
More news about: Biohaven Ltd.
Aug 06, 2026, 07:00 ET Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
arthritis (RA). Insmed plans to initiate a Phase 1 trial in healthy volunteers in the third quarter of 2026.Neuro & Other RareINS1201Insmed continues to enroll patients in the Phase 1 ASCEND clinical study of INS1201, an intrathecally delivered
More news about: Insmed Incorporated
Aug 06, 2026, 06:55 ET Core Natural Resources Reports Second Quarter 2026 Results
projected. These risks and uncertainties include, without limitation, uncertainties regarding the ability of Core to mine, upgrade, process, and extract rare earth elements and critical minerals from its existing mines, including uncertainties regarding the financial impacts of such activities; risks related
More news about: Core Natural Resources
Aug 06, 2026, 05:22 ET Rare Cannabinoid Company Highlights the CBC Cannabinoid as Consumer Interest in Rare Cannabinoids Continues to Grow
in hemp, while expanding consumer education about rare cannabinoids beyond CBD and THC.HONOLULU, Aug. 6, 2026 /PRNewswire/ -- Rare Cannabinoid Company, a pioneer in rare cannabinoids and hemp-derived cannabinoid products,
More news about: Rare Cannabinoid Company
Aug 06, 2026, 00:51 ET Fosun International Wins Three Awards from Global Banking & Finance Review, Gaining International Recognition for its ESG Performance, Corporate Social Responsibility, and Brand Strength
therapeutic areas such as oncology, immunology and inflammation, and neurodegenerative diseases, while actively expanding into cardiometabolic diseases and rare diseases. This approach enables the development of high valued competitive pipelines and comprehensive healthcare solutions. Meanwhile, it continues
More news about: Fosun
Aug 05, 2026, 21:05 ET Galibra Neuroscience Receives FDA Orphan Drug and Rare Pediatric Disease Designations for SSADH Deficiency Gene Therapy
an ultra-rare neurometabolic disorderBOSTON, Aug. 5, 2026 /PRNewswire/ -- Galibra Neuroscience announced a significant regulatory milestone with the receipt of both Orphan Drug Designation (ODD) and Rare Pediatric
More news about: Galibra Neuroscience
Aug 05, 2026, 20:00 ET INVESTOR NOTICE: Bloom Energy Corporation Investors with Substantial Losses Have Opportunity to Lead the Bloom Energy Class Action Lawsuit - BE
manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation in the United States and internationally. Scandium is a rare earth metal used as a dopant to stabilize the zirconia-based ceramic electrolyte in Bloom Energy's solid oxide fuel cells.The Bloom Energy
More news about: Robbins Geller Rudman & Dowd LLP
Aug 05, 2026, 18:10 ET Exceptional Craftsmanship Meets Arizona Roads: Find a Mercedes-Maybach in Scottsdale
these exceptional vehicles through specialized convenience services, because the dealership ships vehicles nationwide upon request. Thus, acquiring a rare luxury automobile remains smooth and straightforward regardless of where the buyer resides.Company Leadership Shares Vision for Luxury Automotive
More news about: Mercedes-Benz of Scottsdale
Aug 05, 2026, 16:15 ET Energy Fuels Announces Q2-2026 Results
be used by Energy Fuels to produce rare earth metals, alloys and magnets essential to the automotive, robotics, data center, energy and defense industries. The expansion of the Company's existing light-rare earth oxide production capacity to also produce heavy-rare earth oxides is a critical step in
More news about: Energy Fuels Inc.
Aug 05, 2026, 16:15 ET Tronox Reports Second Quarter 2026 Financial Results
Company generated free cash flow of $60 million. Capital expenditures were $45 million.Rare EarthsTronox continued to advance its rare earths strategy during the quarter, with a clear focus on moving further downstream in a disciplined manner.
More news about: Tronox Holdings plc
Aug 05, 2026, 16:01 ET Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results
GPP.In July 2026, Vanda announced that the FDA had granted Rare Pediatric Disease Designation to VCA-894A, Vanda's investigational antisense oligonucleotide therapy for the treatment of Charcot-Marie-Tooth disease, axonal, type 2S (CMT2S), a rare, serious, and progressive inherited neurological disorder.Vanda
More news about: Vanda Pharmaceuticals Inc.
Aug 05, 2026, 15:08 ET We're Amid an Active West Nile Virus Season; Here's How to Protect Yourself and Your Family
of cases go even higher," said Dr. Jorge Parada, medical adviser for NPMA. "About one in five people develops a fever, headache or body aches, but in rare cases, the virus can cause severe neurological illness that requires hospitalization and can even be fatal. That's why mosquitoes aren't only a nuisance
More news about: National Pest Management Association